|
|
||||||||
CUTTING EDGE |

*
Department of Cell Biology and Histology, Cellular Immunology Group, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; and
Department of Immunohematology and Bloodbank, Leiden University Medical Center, Leiden, The Netherlands
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Interestingly, GC B lymphocytes have an endonuclease in their nuclei that is readily activated when the B cell is detached from its microenvironment but is effectively silenced as soon as the contact with FDCs is restored in vitro (5, 6). Recently, we have shown that, in addition to and downstream of their caspase cascade, GC B lymphocytes have a thus far unidentified cathepsin activity that controls DNA fragmentation (7).
The mechanism by which FDCs silence apoptosis in adhering B cells is not clear. Freshly isolated single GC B cells have little caspase-3 activity, but this increases dramatically within a few hours at 37°C (7). Activation of caspases can be induced by signals derived from death receptors (DR) that belong to the TNFR1 family (8). GC B lymphocytes express Fas/APO-1/CD95, and this receptor is part of a well-studied DR pathway (9). Ligation of this DR results in the formation of an internal death-inducing signaling complex (DISC). When Fas is activated, the adapter molecule Fas-associated death domain will bind with its C-terminal death domain to Fas. The N-terminal death effector domain of the adapter molecule binds to the death effector domain of caspase-8, resulting in activation of this enzyme, followed by activation of caspase-3 (8). Fas ligation can induce cell death by two different routes. The type I cell death route implies the rapid formation of the DISC with high levels of active caspase-8. Alternatively, a type II cell death route involves low levels of DISC formation and caspase-8 activation. In this situation, amplification of the apoptotic signal involves loss of mitochondrial integrity, leading to cytochrome c release and consequent activation of caspase-9 (10).
Fas-associated death domain-like IL-1-converting enzyme-like inhibitory proteins (FLIPs) can inhibit both death routes. FLIPs were first identified as viral products that interfere with DR-mediated elimination of infected cells (11). Cellular homologues of viral FLIPs (cFLIPs) have been found as well (12). At least two splice variants have been described, a short and a long isoform (FLIPL), which are both capable of inhibiting DR-induced apoptosis. Both cFLIP variants can block caspase-8 activation, but cFLIPL is more potent (13).
Here, we show that cFLIPL is highly expressed in GC B cells and is associated with survival of the cells. Its expression is critically dependent on physical interaction of these B cells with FDCs. In addition, cFLIPL expression is sustained by CD40 ligation as well, thereby giving a clue as to how selected GC B lymphocytes might be able to escape the FDC network without undergoing apoptosis (i.e., by interaction with a proper T cell).
| Materials and Methods |
|---|
|
|
|---|
B lymphocytes and FDCs were isolated from human tonsils as described previously (7). A total of 1 x 106/ml purified GC B cells were incubated in IMDM with 10% FCS (HyClone Laboratories, Logan, UT) for 5 h at 37°C. GC B cells were incubated with or without the cathepsin inhibitor E64d (Scientific Marketing Associates, Barnet, U.K.). Fas ligation was done with the anti-Fas Ab CH11 (Immunotech, Luminy, France). CD40 ligation was done with a CD40 ligand (L)-transfected L cell line (the kind gift of Dr. C. van Kooten, Leiden University Medical Center, Leiden, The Netherlands). FDC-enriched fractions were incubated for 16 h at 37°C, and the resultant FDC-B cell clusters were purified by 1 x g sedimentation on 30% FCS (HyClone) in IMDM. These clusters were monitored under a microscope to ensure that no single cells were present. Clusters were incubated at 37°C for 5 h with or without anti-Fas Abs.
Detection of apoptotic parameters
Phosphatidyl serine (PS) exposure was assessed after annexin V and propidium iodide (PI) double staining using the Apo Target annexin V FITC apoptosis kit (Biosource Europe, Fleurus, Belgium). DNA strand breaks were analyzed by dUTP-fluorescein labeling using the in situ cell death detection method (Roche Diagnostics, Mannheim, Germany) according to the instructions of the manufacturer. PS exposure and DNA strand breaks were analyzed by FACS. Caspase-8 activity was determined using a caspase-8 fluorometric kit (R&D Systems, Minneapolis, MN) using IETD-7-amino-4-trifluoromethyl coumarin (AFC) as a substrate. AFC release was measured using a Wallac Vitor 1420 multilabel counter (EG & G Wallac, Turku, Finland).
Western blotting of cFLIP was done with 30 µg protein/lane, and expression of cFLIP was assessed using the FLIP-specific mAb Nf6. For caspase-8, 100 µg protein was applied per lane, and caspase-8 was detected using the mAb c1 (both Nf6 and c1 mAbs were kind gifts of P. H. Krammer, German Cancer Research Center, Heidelberg, Germany). Blots were stained with the peroxidase-conjugated rabbit anti-mouse Ig (Dako, Glostrup, Denmark), and Lumi-Light PLUS Western blotting substrate (Roche Diagnostics).
| Results |
|---|
|
|
|---|
GC B cells undergo rapid apoptosis upon in vitro culture.
This process is autonomous (i.e., it does not require an inducing death
receptor signal). Typically, 4050% of the cells express PS within
5 h (Fig. 1
A). This is
definitely accelerated after ligation of Fas with the CH11 mAb,
indicating that the Fas route is functional in these cells. Ligation of
CD40 profoundly inhibits PS expression.
|
GC B lymphocytes contain cFLIPL, that decays rapidly in single cells
Freshly isolated GC B cells express cFLIPL,
as shown by Western blotting (Fig. 2
).
Upon incubation at 37°C, this protein rapidly decays and is virtually
gone after 5 h. Remarkably, ligation of CD40 with a CD40L leads to
sustained expression of the cFLIPL (Fig. 2
A). Also, if GC B lymphocytes are cultured with FDCs and
the B cells are recovered from these clusters, the expression of
cFLIPL is maintained (Fig. 2
B). These
data imply that CD40 ligation (presumably by T cells) and physical
contact with FDCs are powerful signals to maintain
cFLIPL expression in GC B cells and, hence, may
prevent DR-induced caspase activation.
|
As we recently published, GC B lymphocytes have a cathepsin-like
activity that is instrumental in their rapid DNA fragmentation
(7). To find out whether this cathepsin may be responsible
for the disappearance of cFLIPL, the general
cathepsin inhibitor E64d was added, and cFLIPL
expression was followed. As seen in Fig. 3
, E64d effectively blocks the formation
of DNA strand breaks (Fig. 3
B) but leaves PS exposure
unhampered (Fig. 3A
). Also, addition of E64d to isolated GC B
lymphocytes did not prevent the disappearance of
cFLIPL from these cells. These data indicate that
cFLIPL decay is independent of cathepsin
activity. Similar results were obtained when isolated GC B cells were
incubated with the caspase inhibitors z-VAD-fmk or z-DEVD-fmk (data not
shown). Altogether, these data indicate that the disappearance of
cFLIPL is an initial event in the triggering of
apoptosis in GC B cells and not a result of
apoptosis-associated proteolysis in these cells.
|
| Discussion |
|---|
|
|
|---|
A role for Fas in the selection of high affinity B cells has recently been strengthened, because lpr mice (who lack functional Fas) show impaired selection of high affinity B lymphocytes in GC reactions (14). It remains unclear whether Fas must be ligated by FasL or, alternatively, Fas is activated spontaneously. In GCs, an obvious FasL source is lacking, as only few cells express this L. FasL expression has been demonstrated on scattered nonlymphoid cells, but in tonsils, the FasL is mainly expressed on plasma cells (15). Caspase-8 activation is strongly inhibited by cFLIP (13). We have shown here that freshly isolated GC B cells contain the 55-kDa isoform of cFLIP, cFLIPL. Naive and memory B cells express much lower amounts (data not shown). None of these B cell fractions expressed the short isoform of cFLIP.
Upon incubation of isolated GC B lymphocytes in vitro,
cFLIPL is rapidly degraded and is virtually
absent after 5 h. Several experiments argue in favor of the idea
that this decay of cFLIPL is a triggering event
for caspase activation rather than a result of general proteolysis
during apoptosis. For instance, inhibition of cathepsin
activity by the general cathepsin inhibitor E64d did not prevent
cFLIPL degradation (Fig. 3C
). Similar results
were found when caspases were blocked by the caspase inhibitors
z-VAD-fmk or z-DEVD-fmk (not shown). In addition, Hennino et al.
(16) have recently studied the composition of the DISC in
GC B lymphocytes at different time points. They demonstrated that
cFLIPL disappearance from the DISC is virtually
complete within 10 min after Fas ligation, indicating that it must be
an initial step rather than a result of apoptosis.
Our data suggest an important role of early cFLIPL decay and caspase-8 activation typical of a type I route of cell death in GC B lymphocytes. However, as we showed earlier, GC B cell apoptosis also includes reduction of mitochondrial membrane potential (7). Mitochondria are involved in both the type I and II routes of cell death, but their inactivation is not strictly necessary for the type I route (8). Transgenic overexpression of Bcl-2 or Bcl-xL, proteins involved in inhibition of mitochondrial cytochrome c release, inhibits GC B cell apoptosis, indicating an important role for the type II cell death route as well (17, 18). In tonsillar B lymphocytes, it has been shown that especially Bcl-xL expression is associated with survival, arguing in favor of a mitochondrial involvement in GC B cell apoptosis (19).
By contrast, the recent data of Defrance and coworkers using selective inhibitors of either caspase-8 or caspase-9 strongly suggest that apoptosis of human tonsillar GC B cells in vitro predominantly depends on caspase-8 activity, not on caspase-9 activity (16). This is in line with their earlier data showing that, in CD40L-activated virgin B cells, Fas-induced cell death bypasses the mitochondrial pathway (20).
In our experiments, cFLIPL decay is profoundly inhibited when GC B lymphocytes are either in contact with FDCs or with a CD40L-transfected cell line. The CD40-mediated signal requires some time because simultaneous CD40 ligation and anti-Fas treatment does not inhibit apoptosis, whereas CD40 ligation for 4 h followed by anti-Fas treatment results in inhibition of apoptosis (data not shown). The contact with FDCs effectively protects GC B lymphocytes against Fas-mediated cell death. The signaling conditions for this anti-Fas insensitivity are not clear, but cell to cell contact between FDCs and B cells is important (21). The FDC-derived signal acts independently of CD40 signals, Ig receptors, or adhesion molecules (5, 22). Bcl-2 seems not to be involved because this protein is only present at low levels in GC B lymphocytes and is down-regulated on B cells in contact with FDCs (23, 24).
The data presented here may provide a clue as to how selected GC B cells are kept alive in the FDC network. Moreover, because cFLIPL expression is maintained by CD40 ligation as well, it may be hypothesized that activated T cells in the GC that can rapidly express large amounts of the L (25) are the permissive factor that help the putative memory B cells to leave the GC for further differentiation.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Cornelis de Groot, Department of Cell Biology and Histology, Cellular Immunology Group, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands. E-mail address: c.degroot{at}amc.uva.nl ![]()
3 Abbreviations used in this paper: GC, germinal center; FDC, follicular dendritic cell; DR, death receptor; DISC, death-inducing signaling complex; FLIP, Fas-associated death domain-like IL-1-converting enzyme-inhibitory protein; cFLIP, cellular homologue of viral FLIP; FLIPL, long isoform of FLIP; PS, phosphatidyl serine; L, ligand; AFC, 7-amino-4-trifluoromethyl coumarin: PI, propidium iodide. ![]()
Received for publication February 22, 2001. Accepted for publication April 4, 2001.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. Alabyev, R. Vuyyuru, and T. Manser Influence of Fas on the regulation of the response of an anti-nuclear antigen B cell clonotype to foreign antigen Int. Immunol., October 1, 2008; 20(10): 1279 - 1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Goval, C. Thielen, C. Bourguignon, R. Greimers, E. Dejardin, Y. S. Choi, J. Boniver, and L. de Leval The prevention of spontaneous apoptosis of follicular lymphoma B cells by a follicular dendritic cell line: involvement of caspase-3, caspase-8 and c-FLIP Haematologica, August 1, 2008; 93(8): 1169 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. van Nierop, F. J.M. Muller, J. Stap, C. J.F. Van Noorden, M. van Eijk, and C. de Groot Lysosomal Destabilization Contributes to Apoptosis of Germinal Center B-lymphocytes J. Histochem. Cytochem., December 1, 2006; 54(12): 1425 - 1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Barrington, M. Zhang, X. Zhong, H. Jonsson, N. Holodick, A. Cherukuri, S. K. Pierce, T. L. Rothstein, and M. C. Carroll CD21/CD19 Coreceptor Signaling Promotes B Cell Survival during Primary Immune Responses J. Immunol., September 1, 2005; 175(5): 2859 - 2867. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. F. Muris, S. A. G. M. Cillessen, W. Vos, I. S. van Houdt, J. A. Kummer, J. H. J. M. van Krieken, N. M. Jiwa, P. M. Jansen, H. C. Kluin-Nelemans, G. J. Ossenkoppele, et al. Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas Blood, April 1, 2005; 105(7): 2916 - 2923. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sacedon, B. Diez, V. Nunez, C. Hernandez-Lopez, C. Gutierrez-Frias, T. Cejalvo, S. V. Outram, T. Crompton, A. G. Zapata, A. Vicente, et al. Sonic Hedgehog Is Produced by Follicular Dendritic Cells and Protects Germinal Center B Cells from Apoptosis J. Immunol., February 1, 2005; 174(3): 1456 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dutton, J. D. O'Neil, A. E. Milner, G. M. Reynolds, J. Starczynski, J. Crocker, L. S. Young, and P. G. Murray Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death PNAS, April 27, 2004; 101(17): 6611 - 6616. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Raman, R. S. Akondy, S. Rath, V. Bal, and A. George Ligation of CD27 on B Cells In Vivo during Primary Immunization Enhances Commitment to Memory B Cell Responses J. Immunol., December 1, 2003; 171(11): 5876 - 5881. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Schmitz, A. Krueger, S. Baumann, H. Schulze-Bergkamen, P. H. Krammer, and S. Kirchhoff An IL-2-Dependent Switch Between CD95 Signaling Pathways Sensitizes Primary Human T Cells Toward CD95-Mediated Activation-Induced Cell Death J. Immunol., September 15, 2003; 171(6): 2930 - 2936. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jinquan, H. H. Jacobi, C. Jing, A. Millner, E. Sten, L. Hviid, L. Anting, L. P. Ryder, C. Glue, P. S. Skov, et al. CCR3 Expression Induced by IL-2 and IL-4 Functioning as a Death Receptor for B Cells J. Immunol., August 15, 2003; 171(4): 1722 - 1731. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Muscarella and S. E. Bloom Cross-linking of Surface IgM in the Burkitt's Lymphoma Cell Line ST486 Provides Protection against Arsenite- and Stress-induced Apoptosis That Is Mediated by ERK and Phosphoinositide 3-Kinase Signaling Pathways J. Biol. Chem., January 31, 2003; 278(6): 4358 - 4367. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Flano, I.-J. Kim, D. L. Woodland, and M. A. Blackman {gamma}-Herpesvirus Latency Is Preferentially Maintained in Splenic Germinal Center and Memory B Cells J. Exp. Med., November 18, 2002; 196(10): 1363 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Thomas, A. Kallenborn, C. Wickenhauser, J. L. Schultze, A. Draube, M. Vockerodt, D. Re, V. Diehl, and J. Wolf Constitutive Expression of c-FLIP in Hodgkin and Reed-Sternberg Cells Am. J. Pathol., April 1, 2002; 160(4): 1521 - 1528. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |